HT
Headlands Technologies’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125K | Buy |
+6,119
| New | +$125K | 0.01% | 582 |
|
|
2025
Q1 | – | Sell |
-3,212
| Closed | -$81.2K | – | 1194 |
|
|
2024
Q4 | $81.2K | Buy |
+3,212
| New | +$81.2K | 0.01% | 708 |
|
|
2024
Q3 | – | Sell |
-9,182
| Closed | -$340K | – | 1234 |
|
|
2024
Q2 | $340K | Buy |
9,182
+5,669
| +161% | +$210K | 0.04% | 357 |
|
|
2024
Q1 | $147K | Buy |
+3,513
| New | +$147K | 0.04% | 453 |
|
|
2023
Q4 | – | Sell |
-718
| Closed | -$19.8K | – | 985 |
|
|
2023
Q3 | $19.8K | Sell |
718
-3,266
| -82% | -$89.9K | 0.01% | 586 |
|
|
2023
Q2 | $135K | Buy |
+3,984
| New | +$135K | 0.04% | 340 |
|